Information Provided By:
Fly News Breaks for March 29, 2017
ESPR
Mar 29, 2017 | 16:25 EDT
UBS analyst Martin Auster assumed coverage of Esperion with a Buy rating and $52 price target, up from the firm's prior Neutral rating.
News For ESPR From the Last 2 Days
ESPR
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here
ESPR
Mar 27, 2024 | 10:47 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here